NextCell Pharma AB
556965-8361ActiveDeveloping pioneering cell therapies for autoimmune diseases and diabetes.
Oversikt
- Ukjent
- Ansatte
- Ukjent
- Omsetning
- 2014
- Grunnlagt
Nøkkelbeslutningstakere
Mathias Svahn
Chief Executive Officer
Eric Gustafsson
CFO
Edvard Smith
Medical Director
Lindsay Davies
Board Member
+8 flere kontakter i Funnelfeedr
Beskrivelse
NextCell Pharma AB is a Swedish biopharmaceutical company focused on revolutionizing treatment for severe and incurable diseases using cell therapies. The company operates three core business areas: ProTrans, Cellaviva, and QVance, all centered around advanced therapy medicinal products (ATMPs). The...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556965836101
Beslutningstakere
12 kontakter i FunnelfeedrMathias Svahn
Chief Executive Officer
Eric Gustafsson
CFO
Edvard Smith
Medical Director
Lindsay Davies
Board Member
Sofia Sisay
Head of Clinical Trials
Hans-Peter Ekre
Chairman of the Board
Eva Sjökvist Saers
Board Member
Camilla Myhre Sandberg
Board member
Sofie Falk Jansson
CEO of Cellaviva
Andre kontakter
Per-Ola Carlsson
Advisor
Eric Strati
Advisor
Angela Vollstedt
Advisor
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrCellaviva AB
5–9 ansatteScandinavia's largest private bank storing family stem cells for future health.
QVance AB
1–4 ansatteSpecialist quality control analytics provider for cell and gene therapies.
Xintela AB
10–19 ansatteDeveloping stem cell and targeted cancer therapies for unmet needs.
Xbrane Biopharma AB
20–49 ansatteDeveloping cost-effective biosimilars using proprietary platform technology.
Swedish StromaBio AB
1 ansatteClinical stage biopharma developing MSC therapies for ARDS and Alzheimer's.
Utforsk mer
Spørsmål om NextCell Pharma AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo